eFFECTOR Therapeutics CEO Stephen Worland's 2022 pay rises 13% to $3.8M
eFFECTOR Therapeutics reports 2022 executive compensation
By ExecPay News
Published: May 12, 2023
eFFECTOR Therapeutics reported fiscal year 2022 executive compensation information on May 12, 2023.
In 2022, five executives at eFFECTOR Therapeutics received on average a compensation package of $1.8M, a 8% decrease compared to previous year.
Average pay of disclosed executives at eFFECTOR Therapeutics
Stephen T. Worland, Chief Executive Officer, received $3.8M in total, which increased by 13% compared to 2021. 78% of Worland's compensation, or $3M, was in option awards. Worland also received $254K in non-equity incentive plan, $567K in salary, as well as $34K in other compensation.
Michael Byrnes, Chief Financial Officer, received a compensation package of $2M, which increased by 59% compared to previous year. 68% of the compensation package, or $1.4M, was in option awards.
Alana McNulty, Former Chief Business Officer, earned $1.6M in 2022, a 6% decrease compared to previous year.
Premal Patel, Chief Medical Officer, received $936K in 2022, which decreases by 38% compared to 2021.
Douglas Warner, Chief Medical Officer, earned $712K in 2022.
Related executives
You may also like
Source: SEC filing on May 12, 2023.